Vertigo News and Research

Latest Vertigo News and Research

European Commission approves ViiV Healthcare's Tivicay for treatment of HIV infected adults

ViiV Healthcare today announced that the European Commission has approved Tivicay (dolutegravir), an integrase inhibitor, for use in combination with other anti-retroviral medicinal products for the treatment of HIV infected adults and adolescents above 12 years of age.

21 Jan 2014

First patient enrolled in Otonomy's pivotal Phase 2b study of OTO-104 for Meniere's disease

Otonomy, Inc., a clinical stage biopharmaceutical company developing innovative therapeutics for diseases and disorders of the inner and middle ear, today announced enrollment of the first patient in its pivotal Phase 2b study of OTO-104 for the reduction of vertigo in patients with unilateral Meniere's disease.

11 Dec 2013

Researchers may have figured out ways to attack Meniere's disease

Researchers at University of Colorado School of Medicine may have figured out what causes Meniere's disease and how to attack it. According to Carol Foster, MD, from the department of otolaryngology and Robert Breeze, MD, a neurosurgeon, there is a strong association between Meniere's disease and conditions involving temporary low blood flow in the brain such as migraine headaches.

7 Dec 2013

Eisai reports new data analyses on FYCOMPA (Perampanel) at AES meeting

Today, Eisai Inc. announced that 16 abstracts highlighting new data analyses on FYCOMPA (perampanel) will be presented at the 67th annual American Epilepsy Society (AES) meeting, taking place in Washington, D.C. from December 6 – 10.

6 Dec 2013

Meclizine drug has the potential to treat certain infectious diseases and cancer

Meclizine, an over-the-counter drug used for decades to treat nausea and motion sickness, has the potential for new uses to treat certain infectious diseases and some forms of cancer, according to Dr. Vishal M. Gohil, Texas A&M AgriLife Research biochemist.

31 Oct 2013

NTRR announces first phase of development on horticultural post-production system

As part of an ambitious strategy to gain market share in a medical marijuana (MMJ) sector forecast to reach $6 billion over the next five years, Neutra Corp. (OTCBB: NTRR) announced today that the first phase of development is now underway on a horticultural post-production system that could soon revolutionize the time and care needed to deliver medicinal cannabis to patients.

13 Aug 2013

Scientists identify key neurons that sense unexpected motion and have implications for motion sickness

It happens to all of us at least once each winter in Montreal. You're walking on the sidewalk and before you know it you are slipping on a patch of ice hidden under a dusting of snow.

29 Jul 2013

Cost of emergency room visits for severe dizziness projected to reach $4.4 billion by 2015

A new Johns Hopkins research report says emergency room visits for severe dizziness have grown exponentially in recent years, with costs topping $3.9 billion in 2011 and projected to reach $4.4 billion by 2015.

18 Jul 2013

Diclegis delayed-release tablets for NVP treatment now eligible for Medicaid coverage

Duchesnay USA today announced that Diclegis (doxylamine succinate 10mg, pyridoxine hydrochloride 10mg) delayed-release tablets for the treatment of nausea and vomiting of pregnancy, more commonly known as morning sickness, is now available for coverage under the state and federal Medicaid program effective July 1st, 2013.

9 Jul 2013

U.S. medical marijuana industry continues to grow as new bill legalizes MMJ in New Hampshire

As Neutra Corp. works to deliver new innovations to the U.S. medical marijuana industry, the market for those innovations continues to grow. Last week, lawmakers passed a bill to make New Hampshire the 19th state to approve medical marijuana prescriptions for patients with chronic or terminal illnesses.

2 Jul 2013

Neutra finalizes LOI with exciting new partner

Neutra Corp., a rapidly-growing provider of all-natural wellness solutions, announced today it has finalized a letter of intent (LOI) with an exciting new partner to grab a share of the exploding $1.7 billion medical marijuana (MMJ) industry.

24 Jun 2013

U.S. MMJ market to quadruple in size over the next five years, predict analysts

Neutra Corp., a provider of all-natural wellness solutions, welcoms a new law passed in Nevada last week allowing medical marijuana patients to obtain their medicine from dispensaries at last.

17 Jun 2013

New study tests vestibular prosthesis to help restore balance for people with Meniere's disease

Many disorders of the inner hear which affect both hearing and balance can be hugely debilitating and are currently largely incurable. Cochlear implants have been used for many years to replace lost hearing resulting from inner ear damage.

14 Jun 2013

FDA approves Novartis' Ilaris for treatment of active systemic juvenile idiopathic arthritis

Novartis announced that the US Food and Drug Administration has approved Ilaris (canakinumab) for the treatment of active systemic juvenile idiopathic arthritis in patients aged 2 years and older.

10 May 2013

Diagnostic hallmarks of POTS identified

US researchers have identified a constellation of symptoms that are associated with a diagnosis of postural tachycardia syndrome in adolescent patients with headache.

25 Apr 2013

Study explores views, beliefs about triggers of Meniere's disease symptoms

A report in one of the last issue of Psychotherapy and Psychosomatics addresses the physical and psychological triggers for attacks in Meniere's disease.

4 Apr 2013

Columbia University Medical Center, NewYork-Presbyterian Hospital present research works at AAN meeting

The following research from Columbia University Medical Center and NewYork-Presbyterian Hospital is being presented at the 65th annual meeting of the American Academy of Neurology, March 16-23, 2013, in San Diego.

18 Mar 2013

New bedside electronic device can determine the cause of severe dizziness

A bedside electronic device that measures eye movements can successfully determine whether the cause of severe, continuous, disabling dizziness is a stroke or something benign, according to results of a small study led by Johns Hopkins Medicine researchers.

6 Mar 2013

AHRF to present free symposium on dizziness and balance disorders

The American Hearing Research Foundation will present a free, day-long educational symposium on dizziness and balance disorders on Saturday, April 6 at the Hilton Suites Chicago/Oakbrook in Oakbrook, Illinois.

27 Feb 2013

Migraine, epilepsy and genetics: an interview with Dr. Melodie Winawer

This work is the product of an extraordinary consortium called the Epilepsy Phenome/Genome project (EPGP). It is a consortium of 27 centres in the U.S. and internationally with several hundred physicians and staff who have worked together to enrol more than 4000 patients with epilepsy and their family members.

7 Feb 2013

Vertigo News and Research

Latest Vertigo News and Research

European Commission approves ViiV Healthcare's Tivicay for treatment of HIV infected adults

First patient enrolled in Otonomy's pivotal Phase 2b study of OTO-104 for Meniere's disease

Researchers may have figured out ways to attack Meniere's disease

Eisai reports new data analyses on FYCOMPA (Perampanel) at AES meeting

Meclizine drug has the potential to treat certain infectious diseases and cancer

NTRR announces first phase of development on horticultural post-production system

Scientists identify key neurons that sense unexpected motion and have implications for motion sickness

Cost of emergency room visits for severe dizziness projected to reach $4.4 billion by 2015

Diclegis delayed-release tablets for NVP treatment now eligible for Medicaid coverage

U.S. medical marijuana industry continues to grow as new bill legalizes MMJ in New Hampshire

Neutra finalizes LOI with exciting new partner

U.S. MMJ market to quadruple in size over the next five years, predict analysts

New study tests vestibular prosthesis to help restore balance for people with Meniere's disease

FDA approves Novartis' Ilaris for treatment of active systemic juvenile idiopathic arthritis

Diagnostic hallmarks of POTS identified

Study explores views, beliefs about triggers of Meniere's disease symptoms

Columbia University Medical Center, NewYork-Presbyterian Hospital present research works at AAN meeting

New bedside electronic device can determine the cause of severe dizziness

AHRF to present free symposium on dizziness and balance disorders

Migraine, epilepsy and genetics: an interview with Dr. Melodie Winawer

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Vertigo News and Research

Latest Vertigo News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in